Chemours Company Insiders

CC Stock  USD 21.53  0.73  3.51%   
Chemours' insiders are aggressively selling. The analysis of insiders' sentiment of trading Chemours Co stock suggests that all insiders are panicking at this time. Chemours employs about 6.2 K people. The company is managed by 36 executives with a total tenure of roughly 132 years, averaging almost 3.0 years of service per executive, having 172.22 employees per reported executive.
Mark Vergnano  CEO
President, Chief Executive Officer, Director
Dawn Farrell  Chairman
Independent Chairman of the Board

Chemours' Insider Buying Vs Selling

0

 
Selling
 
Buying

Latest Trades

2024-11-07Alvenia ScarboroughDisposed 7500 @ 20.64View
2024-08-06Diane I PichoDisposed 73 @ 19.04View
Monitoring Chemours' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Chemours Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Chemours' Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Chemours' future performance. Based on our forecasts, it is anticipated that Chemours will maintain a workforce of about 8100 employees by December 2024.
 
Yuan Drop
 
Covid

Chemours Management Team Effectiveness

The company has Return on Asset (ROA) of 0.0397 % which means that for every $100 of assets, it generated a profit of $0.0397. This is way below average. Likewise, it shows a return on total equity (ROE) of 0.1102 %, which means that it produced $0.1102 on every 100 dollars invested by current stockholders. Chemours' management efficiency ratios could be used to measure how well Chemours manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.03. The current year's Return On Capital Employed is expected to grow to -0.02. At present, Chemours' Non Currrent Assets Other are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 703.5 M, whereas Total Assets are forecasted to decline to about 7.5 B.
As of November 22, 2024, Common Stock Shares Outstanding is expected to decline to about 140.1 M. In addition to that, Net Income Applicable To Common Shares is expected to decline to about 355.7 M

Chemours Workforce Comparison

Chemours Co is rated below average in number of employees category among its peers. The total workforce of Materials industry is currently estimated at about 251,857. Chemours holds roughly 6,200 in number of employees claiming about 2.46% of all equities under Materials industry.

Chemours Profit Margins

The company has Net Profit Margin (PM) of 0.01 %, which suggests that even a small decline in it sales will erase profits and may result in a net loss, or a negative profit margin. This is way below average. Likewise, it shows Net Operating Margin (NOM) of 0.1 %, which signifies that for every $100 of sales, it has a net operating income of $0.1.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.260.2167
Fairly Up
Slightly volatile

Chemours Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Chemours insiders, such as employees or executives, is commonly permitted as long as it does not rely on Chemours' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Chemours insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-09-01
1.2222
11
9
 124,616 
 5,620 
2024-03-01
0.1667
3
18
 21,103 
 53,752 
2023-12-01
0.6667
4
6
 6,234 
 23,102 
2023-09-01
1.25
10
8
 46,271 
 36,191 
2023-06-01
0.7
14
20
 77,578 
 117,039 
2023-03-01
2.0
52
26
 1,181,362 
 248,824 
2022-12-01
0.25
2
8
 1,225 
 48,199 
2022-06-01
0.875
21
24
 357,776 
 1,041,114 
2022-03-01
1.45
29
20
 586,847 
 56,067 
2021-12-01
0.5
7
14
 168,086 
 396,229 
2021-09-01
0.5833
14
24
 210,537 
 264,324 
2021-06-01
2.0
12
6
 84,289 
 92,694 
2021-03-01
1.3913
32
23
 718,907 
 88,590 
2020-12-01
0.7778
7
9
 282,214 
 388,035 
2020-09-01
1.5
3
2
 4,751 
 5,456 
2020-06-01
12.0
12
1
 107,816 
 289.00 
2020-03-01
2.0909
23
11
 1,785,590 
 527,189 
2019-09-01
2.25
9
4
 68,327 
 15,674 
2019-06-01
2.4286
17
7
 197,214 
 203,581 
2019-03-01
1.4667
22
15
 1,672,048 
 573,590 
2018-09-01
0.1667
1
6
 692.00 
 129,582 
2018-06-01
0.8
12
15
 264,547 
 520,190 
2018-03-01
0.5714
12
21
 218,147 
 100,765 
2017-12-01
0.5625
9
16
 88,761 
 144,463 
2017-09-01
0.6
6
10
 68,597 
 97,589 
2017-06-01
1.6
16
10
 72,787 
 77,111 
2017-03-01
1.2
18
15
 767,188 
 57,114 
2016-12-01
1.0
2
2
 1,649 
 18,989 
2016-06-01
2.5
15
6
 226,999 
 27,482 
2016-03-01
0.619
13
21
 1,168,026 
 53,045 
2015-12-01
2.0
4
2
 39,328 
 19,344 
2015-09-01
33.0
66
2
 2,883,943 
 116.00 
2008-12-01
3.0
3
1
 30,357,248 
 0.00 
2008-06-01
1.9667
59
30
 328,306 
 58,229 
2007-09-01
24.0
24
1
 300,465 
 0.00 
2007-06-01
1.8571
78
42
 94,188 
 48,545 
2006-12-01
3.0
33
11
 37,297 
 68,876 
2006-09-01
1.0645
33
31
 50,890 
 100,000 
2006-06-01
0.5478
86
157
 484,863 
 838,588 
2006-03-01
0.5775
41
71
 309,253 
 961,195 
2005-12-01
6.6
33
5
 42,188 
 10,417 
2005-06-01
1.4348
66
46
 944,550 
 509,897 
2005-03-01
20.0
20
1
 102.00 
 95,000 
2004-12-01
4.6667
28
6
 57,572 
 57,469 
2004-06-01
1.375
33
24
 92,933 
 56,501 
2004-03-01
2.0
8
4
 91.97 
 7,882 
2003-12-01
5.0
10
2
 32,925 
 32,841 
2003-09-01
0.5385
7
13
 83.11 
 301,477 

Chemours Notable Stakeholders

A Chemours stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Chemours often face trade-offs trying to please all of them. Chemours' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Chemours' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Mark VergnanoPresident, Chief Executive Officer, DirectorProfile
Dawn FarrellIndependent Chairman of the BoardProfile
Richard BrownIndependent Chairman of the BoardProfile
Matthew AbbottVice President - Digital and Analytics Platforms LeaderProfile
David SheltonSenior Vice President, General Counsel, SecretaryProfile
Alisha BellezzaPresident - Thermal & Specialized SolutionsProfile
Joseph MartinkoPresident SolutionsProfile
Susan KelliherSenior Vice President – Human Resources and Health ServicesProfile
Gerardo CalderonPresident MaterialsProfile
Eugene SnellPresident - Titanium TechnologiesProfile
Sameer RalhanChief Financial Officer, Senior Vice President, TreasurerProfile
Mark NewmanChief Operating Officer, Senior Vice PresidentProfile
Edwin SparksPresident - Chemical Solutions Business, Titanium TechnologiesProfile
Erich ParkerSenior Vice President of Corporate Communications and Chief Brand Officer.Profile
Shane HostetterSenior CFOProfile
Shane CPASenior CFOProfile
Curtis AnastasioIndependent DirectorProfile
Curtis CrawfordIndependent DirectorProfile
Mary CranstonIndependent DirectorProfile
Bradley BellIndependent DirectorProfile
Erin KaneIndependent DirectorProfile
Sean KeohaneIndependent DirectorProfile
Kristine WellmanGeneral VPProfile
Jonathan LockSenior Vice President and Chief Development OfficerProfile
Amber WellmanChief OfficerProfile
Denise DignamPresident - Advanced Performance MaterialsProfile
Aditya BeriInterim BusinessProfile
Sheryl TelfordChief Sustainability OfficerProfile
Ron CharlesSenior PeopleProfile
Sandra RogersIndependent DirectorProfile
Kurt BonnerMa RelationsProfile
Guillaume PepyIndependent DirectorProfile
Brandon OntjesVice RelationsProfile
Camela WiselChief Accounting Officer, Vice President ControllerProfile
Brian ShayInterim OfficerProfile
Alvenia ScarboroughSenior Vice President - Corporate Communications and Chief Brand OfficerProfile

About Chemours Management Performance

The success or failure of an entity such as Chemours often depends on how effective the management is. Chemours management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Chemours management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Chemours management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets(0.03)(0.03)
Return On Capital Employed(0.02)(0.02)
Return On Assets(0.03)(0.03)
Return On Equity(0.32)(0.31)
Please note, the presentation of Chemours' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Chemours' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Chemours' management manipulating its earnings.

Chemours Workforce Analysis

Traditionally, organizations such as Chemours use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Chemours within its industry.

Chemours Manpower Efficiency

Return on Chemours Manpower

Revenue Per Employee972.1K
Revenue Per Executive167.4M
Net Loss Per Employee38.4K
Net Loss Per Executive6.6M
Working Capital Per Employee217.6K
Working Capital Per Executive37.5M

Complementary Tools for Chemours Stock analysis

When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Commodity Directory
Find actively traded commodities issued by global exchanges
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.